Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Vital Therapies logo

About Vital Therapies Stock (NASDAQ:VTL)

Key Stats

Today's Range
$1.02
$1.08
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
484,671 shs
Average Volume
21.62 million shs
Market Capitalization
$45.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

VTL Stock News Headlines

Lighthouse Center for Vital Living celebrates new building
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
Vardhman Textiles Ltd.
See More Headlines

VTL Stock Analysis - Frequently Asked Questions

Vital Therapies, Inc. (NASDAQ:VTL) posted its quarterly earnings data on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.33) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Bristol-Myers Squibb (BMY), Novavax (NVAX) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/07/2018
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$44.49 million
Optionable
Not Optionable
Beta
3.51
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:VTL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners